No Detail Found!

Gemtuzumab-induced orchitis in a patient with refractory acute promyelocytic leukaemia.

Author(s)
Jalil-ur-Rehman Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Muhammad Kelta Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Khalid Awad Department of Oncology King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Basim Al Beirouti Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Shahzad Nasser Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Muhammad Aslam Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Abstract
We report the case of a 22-year-old Saudi male patient who was treated extensively in the past with various regimens for acute promyelocytic leukaemia that was refractory to all standard treatments. He was ultimately administered Gemtuzumab to induce remission and subjected to an allogeneic bone marrow transplant. However, he developed orchitis, which has not been previously reported with this agent.
Publication Details
Page(s) 596-597
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 22, Issue: 9, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

52

Views